Batulan, Mary Anne T.
HRN: 23-25-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2023
CEFUROXIME 500MG (TAB)
07/19/2023
07/25/2023
ORAL
500mg
BID
Perineal Laceration With Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes